Drug-drug interactions of platinum-based anticancer drugs
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: MORGADO, Manuel (University of Beira Interior, Health Science Faculty, Covilhã, Portugal)
- Co-author(s): Sofia Mendes:Health Science Faculty,University of Beira Interior,Covilhã,Portugal|Sandra Morgado:Pharmaceutical Services,Hospital Centre of Cova da Beira,Covilhã,Portugal|Ema Paulino:,Portuguese Pharmaceutical Society,Lisbon,Portugal|Manuel Morgado:Health Science Faculty,University of Beira Interior,Covilhã,Portugal;Pharmaceutical Services,Hospital Centre of Cova da Beira,Covilhã,Portugal
Detection and management of drug interactions is essential and easier with the support of a computer system.
The Summary of Product Characteristics of these drugs and online databases such as www.drugs.com, www.epocrates.com and www.medscape.com, were used as source of information. Only drugs licensed in the Portuguese pharmaceutical market were.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.